Fundraising Fox

Vico

Founded 2025 · 17 employees on LinkedIn · 7 known investors

Find your way into Vico

VICO provides AI-generated forecasts and event risk ratings that track and triangulate analyst views into continuous time series data. It is aimed at financial professionals for use in financial models, trading strategies, and portfolio management.

AI & Machine LearningData & InfrastructureFintech

Investors · 7

AIN VenturesNew York · $500K – $1M
Multiball CapitalLos Angeles
Droia VenturesreportedLeuven · $540K
EQT Life SciencesreportedLuxembourg · $11M – $66M
EurazeoreportedParis
Kurma Partnersreported · 2 sourcesParis · $162K – $10.8M
Pureos Bioventuresreported · 2 sourcesPfäffikon

In the news

Vico Therapeutics Secures €65.8M in Series B Funding Led by Seroba and Kurma Partnerstechnews180.com · Jun 2024Leiden-based Vico Therapeutics raises €11.5M - Silicon Canalssiliconcanals.com · Jun 2024Vico Therapeutics Raises $60M in Series B Financingfinsmes.com · Jan 2024Vico Raises $31M to Advance Therapies for Huntington's, CNS Disordershuntingtonsdiseasenews.com · Aug 2020Biotech VICO Therapeutics raises $31 million (€27 million) in Series A financing round to advance therapies for rare central nervous system diseases – Vico Therapeuticsvicotx.com · Jul 2020Vico Therapeutics Announces $60 million (€54 million) Series B Financing to Advance VO659 Clinical-Stage Program for Rare Neurological Diseases and Expand Pipelinestreetinsider.com

Frequently asked questions

What does Vico do?
VICO provides AI-generated forecasts and event risk ratings that track and triangulate analyst views into continuous time series data. It is aimed at financial professionals for use in financial models, trading strategies, and portfolio management.
Who are Vico's investors?
Vico's investors include AIN Ventures, Multiball Capital, Droia Ventures, EQT Life Sciences, Eurazeo, Kurma Partners, Pureos Bioventures.